RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

DARPA: Subcutaneous chip to detect COVID-19 coronavirus

Product
Developers: DARPA
Date of the premiere of the system: April 2021
Branches: Pharmaceuticals, medicine, healthcare

2021: Creating an implantable chip under the skin that detects COVID-19 in a few minutes

In mid-April 2021, a military research laboratory USA DARPA developed an implantable chip under the skin that can continuously check blood for new strains of coronavirus and notify the owner of the infection within a few minutes. According to the researchers, the development is undergoing a late stage of testing and will be used by sailors.

A microchip placed in a tissue-like gel tracks various chemical reactions in the body and signals the development of the disease the day before symptoms appear. According to the researchers, the chip implant does not track the user's movement and cannot be used against his desire.

DARPA has developed an implantable chip under the skin that detects COVID-19 in a few minutes
File:Aquote1.png
Thanks to the chip, we can get the necessary information within three to five minutes, "retired Colonel Matt Hepburn explained in an interview with CBS News. - Thus, we reduce the time of diagnosis and accelerate the start of treatment, preventing the infection from developing to severe complications.
File:Aquote2.png

Medical microarrays have been used since 2004, when regulators approved the use of an implantable radio frequency identification (RFID) device that allows doctors to access the medical records of their owners. Since then, scientists have developed implantable microarrays to deliver contraceptives and other drugs, as well as chips that control various health indicators, including heart rate and blood oxygen levels.

Another recent DARPA invention is a filter that can be attached to a dialysis machine to remove coronavirus particles from the blood of seriously ill patients. The filter was tested on "patient 16," the wife of one of the military personnel who was at death due to multiple organ failure and septic shock against the background of COVID-19. After an experimental four-day treatment, the patient fully recovered.[1]

Notes